(2S)-N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-methoxy-2-phenylacetamide

C15H17N3O2 — CID 5330940

IUPAC(2S)-N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-methoxy-2-phenylacetamide
SMILESCO[C@H](C(=O)Nc1cc(C2CC2)[nH]n1)c1ccccc1
InChIInChI=1S/C15H17N3O2/c1-20-14(11-5-3-2-4-6-11)15(19)16-13-9-12(17-18-13)10-7-8-10/h2-6,9-10,14H,7-8H2,1H3,(H2,16,17,18,19)/t14-/m0/s1
InChIKeyIKTSXTHXYZRAPU-AWEZNQCLSA-N
MW271.32 g/mol
LogP2.61
Rot. Bonds5

About (2S)-N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-methoxy-2-phenylacetamide

(2S)-N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-methoxy-2-phenylacetamide (PubChem CID 5330940) has the molecular formula C15H17N3O2 and a molecular weight of 271.32 g/mol. Its IUPAC name is (2S)-N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-methoxy-2-phenylacetamide.

Molecular Properties

Compound Name(2S)-N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-methoxy-2-phenylacetamide
PubChem CID5330940
Molecular FormulaC15H17N3O2
Molecular Weight271.32 g/mol
Exact Mass271.13
IUPAC Name(2S)-N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-methoxy-2-phenylacetamide
SMILESCO[C@H](C(=O)Nc1cc(C2CC2)[nH]n1)c1ccccc1
InChIInChI=1S/C15H17N3O2/c1-20-14(11-5-3-2-4-6-11)15(19)16-13-9-12(17-18-13)10-7-8-10/h2-6,9-10,14H,7-8H2,1H3,(H2,16,17,18,19)/t14-/m0/s1
InChIKeyIKTSXTHXYZRAPU-AWEZNQCLSA-N
XLogP2.61
TPSA67.01 Ų
H-Bond Donors2
H-Bond Acceptors3
Rotatable Bonds5
Heavy Atoms20
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500271.32
LogP ≤ 52.61
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 103

Analyze (2S)-N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-methoxy-2-phenylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(3-methoxyphenyl)acetamide
CID 5331000
(2R)-N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-methoxy-2-phenylacetamide
CID 5330941
N-(5-cyclobutyl-1H-pyrazol-3-yl)-2-(4-methoxyphenyl)acetamide
CID 164609483
N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-methoxy-2-phenylacetamide
CID 11737334
N-[5-[(2S)-2-methoxy-2-phenylacetyl]-4,6-dihydro-1H-pyrrolo[3,4-d]pyrazol-3-yl]benzamide
CID 49798188
2-(cyclopropylmethoxy)-N-[5-(2-methoxyphenyl)-1H-pyrazol-3-yl]acetamide
CID 51099259
2-(Benzyloxy)-N-[4-(4-fluorophenyl)-3-methyl-1H-pyrazol-5-YL]acetamide
CID 53198513
N-(4,5-dimethyl-1H-pyrazol-3-yl)-4-(2,2,2-trifluoroethoxymethyl)benzamide
CID 53554031
2-(Benzyloxy)-N-(3-methyl-4-phenyl-1H-pyrazol-5-YL)acetamide
CID 53198492
2-[(3-methyl-1H-pyrazol-5-yl)amino]-2-oxoethyl 3-fluorobenzoate
CID 46860460
(2R)-N-(3-ethyl-1,4-dimethyl-1H-pyrazol-5-yl)-2-methoxy-2-phenylacetamide
CID 132418327
(2S)-N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-[[(2S)-2-(3,5-difluorophenyl)-2-hydroxyacetyl]amino]propanamide
CID 59385428

Frequently Asked Questions

What is the IUPAC name of (2S)-N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-methoxy-2-phenylacetamide?
The IUPAC name of (2S)-N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-methoxy-2-phenylacetamide (CID 5330940) is (2S)-N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-methoxy-2-phenylacetamide.
What is the SMILES notation for (2S)-N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-methoxy-2-phenylacetamide?
The canonical SMILES for (2S)-N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-methoxy-2-phenylacetamide is CO[C@H](C(=O)Nc1cc(C2CC2)[nH]n1)c1ccccc1.
What is the InChIKey of (2S)-N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-methoxy-2-phenylacetamide?
The InChIKey is IKTSXTHXYZRAPU-AWEZNQCLSA-N. The full InChI is InChI=1S/C15H17N3O2/c1-20-14(11-5-3-2-4-6-11)15(19)16-13-9-12(17-18-13)10-7-8-10/h2-6,9-10,14H,7-8H2,1H3,(H2,16,17,18,19)/t14-/m0/s1.
What are the key properties of (2S)-N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-methoxy-2-phenylacetamide?
(2S)-N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-methoxy-2-phenylacetamide has a molecular weight of 271.32 g/mol, XLogP of 2.61, 5 rotatable bonds, 2 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-methoxy-2-phenylacetamide is sourced from PubChem (CID 5330940), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).